Venus Remedies secures cancer drug approval in Morocco and the Philippines: Rediff Moneynews

Chandigarh, Sep 30 (PTI) Pharmaceutical major Venus Remedies Ltd on Monday said it has received marketing approvals for two key cancer drugs – carboplatin and bortezomib – from Morocco and the Philippines, respectively.

“These approvals are critical to our strategy to expand our oncology offerings and meet increasing global demand for cancer treatments. We are on track to become the leading oncology provider in Southeast Asia,” Saransh Chaudhary, president of Global Critical Care at Venus Remedies, said in a statement.

The Philippine market, the second largest in the ASEAN region, is expected to grow from $400 million in 2022 to $790 million in 2030. The approval of bortezomib will enhance the company's ability to provide advanced cancer solutions in Southeast Asia, the statement said.

In Morocco, where the oncology drug market is expected to reach $150.8 million by 2029, the approval of carboplatin will strengthen Venus Remedies' position in the African oncology market.

Aditi K. Chaudhary, president of the company's international business, said: “These approvals reflect our commitment to providing innovative and accessible healthcare solutions worldwide.”

Venus Remedies, based in Panchkula, now has 15 licenses in Morocco and 69 in the Philippines.